Saba Capital Management, L.P., a beneficial owner, reported a disposal of common shares of abrdn Life Sciences Investors. The form was filed by more than one reporting person, including Saba Capital Management, L.P., among other reporting beneficial owners. The full filing can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. abrdn Life Sciences Investors published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001510281-25-000428), on August 25, 2025, and is solely responsible for the information contained therein.